Affiliation:
1. State Key Laboratory of Quality Research in Chinese Medicines, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology , Macau 999078 , China
Abstract
Abstract
The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has highlighted the pivotal role of the immune response in determining the progression and severity of viral infections. In this paper, we review the most recent studies on the complicated dynamics between SARS-CoV-2 and the host immune system, highlight the importance of understanding these dynamics in developing effective treatments and formulate potent management strategies for COVID-19. We describe the activation of the host's innate immunity and the subsequent adaptive immune response following infection with SARS-CoV-2. In addition, the review emphasizes the immune evasion strategies of the SARS-CoV-2, including inhibition of interferon production and induction of cytokine storms, along with the resulting clinical outcomes. Finally, we assess the efficacy of current treatment strategies, including antiviral drugs, monoclonal antibodies, and anti-inflammatory treatments, and discuss their role in providing immunity and preventing severe disease.
Funder
Science and Technology Development Fund
Publisher
Oxford University Press (OUP)
Reference146 articles.
1. A novel coronavirus genome identified in a cluster of pneumonia cases—Wuhan, China 2019-2020;Tan;China CDC weekly,2020
2. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor;Hoffmann,2020
3. Neuropilin 1: a novel entry factor for SARS-CoV-2 infection and a potential therapeutic target;Chekol Abebe;Biologics: Targets and Therapy,2021
4. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity;Cantuti-Castelvetri;Science,2020
5. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2;Yan;Science,2020